Systematic review of dose-volume parameters in the prediction of esophagitis in thoracic radiotherapy

被引:82
作者
Rose, Jim [2 ]
Rodrigues, George [1 ,3 ]
Yaremko, Brian
Lock, Michael
D'Souza, David
机构
[1] London Hlth Sci Ctr, Dept Radiat Oncol, London Reg Canc Program, London, ON N6A 4L6, Canada
[2] Kingston Reg Canc Ctr, Dept Radiat Oncol, Kingston, ON, Canada
[3] Univ Western Ontario, Dept Epidemiol & Biostat, London, ON N6A 3K7, Canada
关键词
Esophagitis; Lung cancer; Systematic review; Dose-volume histograms; Modeling; CELL LUNG-CANCER; 3-DIMENSIONAL CONFORMAL RADIOTHERAPY; RADIATION-INDUCED ESOPHAGITIS; CONCURRENT CHEMOTHERAPY; DOSIMETRIC PREDICTORS; TOXICITY; THERAPY; CARCINOMA; TRIAL; ESCALATION;
D O I
10.1016/j.radonc.2008.09.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: With dose escalation and increasing use of concurrent chemoradiotherapy, radiation esophagitis (RE) remains a common treatment-limiting acute side effect in the treatment of thoracic malignancies. The advent of 3DCT planning has enabled investigators to study esophageal dose-volume histogram (DVH) parameters as predictors of RE. The purpose of this study was to assess published dosimetric parameters and toxicity data systematically in order to define reproducible predictors of RE, both for potential clinical use, and to provide recommendations for future research in the field. Materials and methods: We performed a systematic literature review of published studies addressing RE in the treatment of lung cancer and thymoma. Our search strategy included a variety of electronic medical databases, textbooks and bibliographies. Both prospective and retrospective clinical studies were included. Information relating to the relationship among measured dosimetric parameters, patient demographics, tumor characteristics, chemotherapy and RE was extracted and analyzed. Results: Eighteen published studies were suitable for analysis. Eleven of these assessed acute RE, while the remainder assessed both acute and chronic RE together. Heterogeneity of esophageal contouring practices, individual differences in information reporting and variability of RE outcome definitions were assessed. Well-described clinical and logistic modeling directly related V-35GY, V-60Gy and SA(55Gy) to clinically significant RE. Conclusions: Several reproducible dosimetric parameters exist in the literature, and these may be potentially relevant in the prediction of RE in the radiotherapy of thoracic malignancies. Further clarification of the predictive relationship between such standardized dosimetric parameters and observed RE outcomes is essential to develop efficient radiation treatment planning in locally advanced NSCLC in the modern concurrent chemotherapy and image-guided IMRT era. (C) 2008 Elsevier Ireland Ltd. All rights reserved. Radiotherapy and Oncology 91 (2009) 282-287
引用
收藏
页码:282 / 287
页数:6
相关论文
共 35 条
[1]   Dosimetric and clinical predictors for radiation-induced esophageal injury [J].
Ahn, SJ ;
Kahn, D ;
Zhou, SM ;
Yu, XL ;
Hollis, D ;
Shafman, TD ;
Marks, LB .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 61 (02) :335-347
[2]   Acute esophageal toxicity in non-small cell lung cancer patients after high dose conformal radiotherapy [J].
Belderbos, J ;
Heemsbergen, W ;
Hoogeman, M ;
Pengel, K ;
Rossi, M ;
Lebesque, J .
RADIOTHERAPY AND ONCOLOGY, 2005, 75 (02) :157-164
[3]   A review of radiation dose escalation trials for non-small cell lung cancer within the radiation therapy oncology group [J].
Bradley, J .
SEMINARS IN ONCOLOGY, 2005, 32 (02) :S111-S113
[4]   Dosimetric correlates for acute esophagitis in patients treated with radiotherapy for lung carcinoma [J].
Bradley, J ;
Deasy, JO ;
Bentzen, S ;
El Naqa, I .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 58 (04) :1106-1113
[5]   Normal tissue complication probability modeling for acute esophagitis in patients treated with conformal radiation therapy for non-small cell lung cancer [J].
Chapet, O ;
Kong, FM ;
Lee, JS ;
Hayman, JA ;
Ten Haken, RK .
RADIOTHERAPY AND ONCOLOGY, 2005, 77 (02) :176-181
[6]  
Choy H, 1999, SEMIN RADIAT ONCOL, V9, P90
[7]   Management of unresectable non-small cell carcinoma of the lung (NSCLC) [J].
Cox, JD ;
Le Chevalier, T ;
Arriagada, R ;
Choy, H ;
Curran, WJ ;
Fukuoka, M ;
Harper, P ;
Komaki, R ;
Le Pechoux, C ;
Lievens, Y ;
Rami-Porta, R ;
Ready, N ;
Sause, W ;
Stuschke, M ;
Thatcher, N .
LUNG CANCER, 2003, 42 :S15-S16
[8]   Multimodality therapy in stage III non-small cell lung cancer [J].
Edelman, MJ ;
Gandara, DR ;
Roach, M ;
Benfield, JR .
ANNALS OF THORACIC SURGERY, 1996, 61 (05) :1564-1572
[9]  
Graham M V, 1996, Front Radiat Ther Oncol, V29, P188
[10]   Accelerated hyperfractionation in patients with non-small cell bronchogenic cancers as a cost-effective and user- and patient-friendly schedule [J].
Herskovic, A ;
Fisher, J ;
Orton, B ;
Lee, CK ;
Chang, JH ;
Sandhu, T ;
Prysby, D ;
Scott, C .
CANCER INVESTIGATION, 2000, 18 (06) :537-543